The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious
Plant-based vaccine against SARS-CoV-2 shows promise
Researchers at Canadian biotechnology company Medicago report that Phase 1 trials of a plant-based vaccine for SARS-CoV-2 are underway and
India Says ‘Minuscule’ Clotting Cases After AstraZeneca Vaccine
NEW DELHI (Reuters) – India has found 26 suspected cases of bleeding and clotting among recipients of the AstraZeneca vaccine,
Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in elderly people, finds study
Antibody response in people aged over 80 is three-and-a-half times greater in those who have the second dose of the
Japan rolls out vaccine slowly, despite looming Olympics
Three months before it hosts the Olympics—the biggest international event since the pandemic began—Japan has fully vaccinated less than one
Why it’s important to call the Johnson & Johnson vaccine review phase a ‘pause’
As the distribution of the Johnson & Johnson vaccine remains on hold while federal health officials review a potential blood-clotting
Rapid mRNA vaccination effectively controls SARS-CoV-2 transmission in long-term care facilities
Vaccine rollouts all over the world are aimed at cutting short the coronavirus disease 2019 (COVID-19) pandemic by inducing antibody-mediated
UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research
The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease
Poland starts J&J COVID-19 jabs, says benefits outweigh risks
FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen
US recommends ‘pause’ for J&J vaccine over clot reports
The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of